| Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases C Cook, NJ Patel, KM D’Silva, TYT Hsu, M DiIorio, L Prisco, LW Martin, ... Annals of the rheumatic diseases 81 (2), 289-291, 2022 | 88 | 2022 |
| SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry J Liew, M Gianfrancesco, C Harrison, Z Izadi, S Rush, S Lawson-Tovey, ... RMD open 8 (1), e002187, 2022 | 44 | 2022 |
| DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: a prospective study M Di Iorio, CE Cook, KMM Vanni, NJ Patel, KM D'Silva, X Fu, J Wang, ... Seminars in arthritis and rheumatism 55, 152025, 2022 | 39 | 2022 |
| Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative … TYT Hsu, KM D'Silva, NJ Patel, J Wang, AA Mueller, X Fu, L Prisco, ... The Lancet Rheumatology 3 (9), e638-e647, 2021 | 38 | 2021 |
| Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study G Qian, X Wang, NJ Patel, Y Kawano, X Fu, CE Cook, KMM Vanni, ... The Lancet Rheumatology 5 (3), e139-e150, 2023 | 34 | 2023 |
| Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study G Figueroa-Parra, EL Gilbert, MO Valenzuela-Almada, S Vallejo, ... The Lancet Rheumatology 4 (11), e765-e774, 2022 | 32 | 2022 |
| Coronavirus Disease 2019 Outcomes Among Recipients of Anti‐CD20 Monoclonal Antibodies for Immune‐Mediated Diseases: A Comparative Cohort Study NJ Patel, KM D'Silva, TYT Hsu, M DiIorio, X Fu, C Cook, L Prisco, L Martin, ... ACR Open Rheumatology 4 (3), 238-246, 2022 | 32 | 2022 |
| Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave Y Kawano, NJ Patel, X Wang, CE Cook, KMM Vanni, EN Kowalski, ... Annals of the Rheumatic Diseases 81 (12), 1742-1749, 2022 | 28 | 2022 |
| Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study NJ Patel, X Wang, X Fu, Y Kawano, C Cook, KMM Vanni, G Qian, ... Seminars in Arthritis and Rheumatism 58, 152108, 2023 | 27 | 2023 |
| Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults ZS Wallace, G Miles, E Smolkina, N Petruski-Ivleva, D Madziva, C Cook, ... Annals of the Rheumatic Diseases 82 (7), 957-962, 2023 | 17 | 2023 |
| Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic C Cook, H Cox, X Fu, Y Zhang, JH Stone, HK Choi, ZS Wallace ACR open rheumatology 3 (12), 834-841, 2021 | 12 | 2021 |
| The association of illness-related uncertainty with mental health in systemic autoimmune rheumatic diseases ZS Wallace, C Cook, L Finkelstein-Fox, X Fu, FV Castelino, HK Choi, ... The Journal of Rheumatology 49 (9), 1058-1066, 2022 | 11 | 2022 |
| Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases NJ Patel, C Cook, K Vanni, X Fu, X Wang, Y Kawano, G Qian, B Hang, ... Annals of the Rheumatic Diseases 82 (4), 565-573, 2023 | 10 | 2023 |
| The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation study G McDermott, X Fu, C Cook, C Ahola, B Doliner, J Hanberg, JH Stone, ... Annals of the rheumatic diseases 81 (10), 1438-1445, 2022 | 10 | 2022 |
| Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy KMM Vanni, NJ Patel, M DiIorio, E Kowalski, G Qian, CE Cook, SY Ritter, ... RMD open 8 (1), e002082, 2022 | 10 | 2022 |
| Assessing the Severity of COVID‐19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning–Derived Chest Radiograph Scores NJ Patel, KM D'Silva, MD Li, TYT Hsu, M DiIorio, X Fu, C Cook, L Prisco, ... Arthritis Care & Research 75 (3), 657-666, 2023 | 8 | 2023 |
| Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19 JD Herman, C Atyeo, Y Zur, CE Cook, NJ Patel, KM Vanni, EN Kowalski, ... medRxiv, 2022 | 6 | 2022 |
| Association of renal transplantation with reduced risk of myocardial infarction and ischemic stroke in ANCA-associated vasculitis: An observational cohort study C Cook, A Jorge, X Fu, J Niles, A Jeyabalan, R Zonozi, JH Stone, Y Zhang, ... Seminars in Arthritis and Rheumatism 51 (6), 1180-1185, 2021 | 6 | 2021 |
| COVID-19 outcomes among users of CD20 inhibitors for immune-mediated diseases: a comparative cohort study NJ Patel, KM D’Silva, TYT Hsu, M DiIorio, X Fu, C Cook, L Prisco, L Martin, ... medRxiv, 2021 | 6 | 2021 |
| Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines against COVID-19 infection among patients with systemic autoimmune rheumatic diseases on immunomodulatory medications CE Cook, NJ Patel, X Fu, X Wang, Y Kawano, KMM Vanni, G Qian, ... The Journal of Rheumatology 50 (5), 697-703, 2023 | 5 | 2023 |
